Filogold Limited 30/06/2022 iXBRL


2 30/06/2022 2022-06-30 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2021-07-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 02621099 2021-07-01 2022-06-30 02621099 2022-06-30 02621099 2020-07-01 2021-06-30 02621099 2021-06-30 02621099 bus:RegisteredOffice 2021-07-01 2022-06-30 02621099 bus:LeadAgentIfApplicable 2021-07-01 2022-06-30 02621099 bus:Director1 2021-07-01 2022-06-30 02621099 bus:Director2 2021-07-01 2022-06-30 02621099 bus:CompanySecretary1 2021-07-01 2022-06-30 02621099 core:LandBuildings core:OwnedOrFreeholdAssets 2022-06-30 02621099 core:FurnitureFittingsToolsEquipment 2022-06-30 02621099 core:WithinOneYear 2022-06-30 02621099 core:WithinOneYear 2021-06-30 02621099 core:AfterOneYear 2022-06-30 02621099 core:AfterOneYear 2021-06-30 02621099 core:ShareCapital 2022-06-30 02621099 core:ShareCapital 2021-06-30 02621099 core:HedgingReserve 2022-06-30 02621099 core:HedgingReserve 2021-06-30 02621099 core:RetainedEarningsAccumulatedLosses 2022-06-30 02621099 core:RetainedEarningsAccumulatedLosses 2021-06-30 02621099 core:HedgingReserve 2021-06-30 02621099 core:HedgingReserve 2020-06-30 02621099 core:LandBuildings core:OwnedOrFreeholdAssets 2021-06-30 02621099 core:FurnitureFittingsToolsEquipment 2021-06-30 02621099 bus:SmallEntities 2021-07-01 2022-06-30 02621099 bus:AuditExemptWithAccountantsReport 2021-07-01 2022-06-30 02621099 bus:FullAccounts 2021-07-01 2022-06-30 02621099 bus:SmallCompaniesRegimeForAccounts 2021-07-01 2022-06-30 02621099 bus:PrivateLimitedCompanyLtd 2021-07-01 2022-06-30
Company registration number: 02621099
Filogold Limited
Unaudited filleted financial statements
30 June 2022
Filogold Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Filogold Limited
Directors and other information
Directors Chaim Yisroel Klagsbald
Mordechai Cik
Secretary Mordechai Cik
Company number 02621099
Registered office 149A Stamford Hill
London
N16 5LL
Accountants Rothfeld & Co
Medcar House
149A Stamford Hill
London
N16 5LL
Bankers Santander Bank Plc
Filogold Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Filogold Limited
Year ended 30 June 2022
As described on the Statement of financial position, the directors of the company are responsible for the preparation of the financial statements for the year ended 30 June 2022, as set out on pages 3 to 8.
You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to us.
Rothfeld & Co
Accountants
Medcar House
149A Stamford Hill
London
N16 5LL
20 March 2023
Filogold Limited
Statement of financial position
30 June 2022
2022 2021
Note £ £ £ £
Fixed assets
Tangible assets 5 255,191 255,191
_______ _______
255,191 255,191
Current assets
Debtors 6 5,402 4,202
Cash at bank and in hand 3,712 16,139
_______ _______
9,114 20,341
Creditors: amounts falling due
within one year 7 ( 119,162) ( 118,562)
_______ _______
Net current liabilities ( 110,048) ( 98,221)
_______ _______
Total assets less current liabilities 145,143 156,970
Creditors: amounts falling due
after more than one year 8 ( 62,141) ( 69,414)
Provisions for liabilities ( 16,200) ( 16,200)
_______ _______
Net assets 66,802 71,356
_______ _______
Capital and reserves
Called up share capital 100 100
Fair value reserve 90,000 90,000
Profit and loss account ( 23,298) ( 18,744)
_______ _______
Shareholders funds 66,802 71,356
_______ _______
For the year ending 30 June 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 20 March 2023 , and are signed on behalf of the board by:
Chaim Yisroel Klagsbald
Director
Company registration number: 02621099
Filogold Limited
Notes to the financial statements
Year ended 30 June 2022
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Medcar House, 149A Stamford Hill, London, N16 5LL.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
4. Employee numbers
The average number of persons employed by the company during the year amounted to 2 (2021: 2 ).
5. Tangible assets
Freehold property Fixtures, fittings and equipment Total
£ £ £
Cost
At 1 July 2021 and 30 June 2022 255,189 538 255,727
_______ _______ _______
Depreciation
At 1 July 2021 and 30 June 2022 - 536 536
_______ _______ _______
Carrying amount
At 30 June 2022 255,189 2 255,191
_______ _______ _______
At 30 June 2021 255,189 2 255,191
_______ _______ _______
6. Debtors
2022 2021
£ £
Other debtors 5,402 4,202
_______ _______
7. Creditors: amounts falling due within one year
2022 2021
£ £
Bank loans and overdrafts 6,000 4,800
Other creditors 113,162 113,762
_______ _______
119,162 118,562
_______ _______
8. Creditors: amounts falling due after more than one year
2022 2021
£ £
Bank loans and overdrafts 62,141 69,414
_______ _______
9. Fair value reserve
Included within other reserves is the fair value reserve as follows:
2022 2021
£ £
At start of year 90,000 90,000
_______ _______
At end of year 90,000 90,000
_______ _______